Show simple item record

2011-04-12Zeitschriftenartikel DOI: 10.1186/1479-5876-9-40
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010
dc.contributor.authorBrinckmann, Sarah
dc.contributor.authorCosta, Kelly Da
dc.contributor.authorGils, Marit J. van
dc.contributor.authorHallengärd, David
dc.contributor.authorKlein, Katja
dc.contributor.authorMadeira, Luisa
dc.contributor.authorMainetti, Lara
dc.contributor.authorPalma, Paolo
dc.contributor.authorRaue, Katharina
dc.contributor.authorReinhart, David
dc.contributor.authorReudelsterz, Marc
dc.contributor.authorRuffin, Nicolas
dc.contributor.authorSeifried, Janna
dc.contributor.authorSchäfer, Katrein
dc.contributor.authorSheik-Khalil, Enas
dc.contributor.authorSköld, Annette
dc.contributor.authorUchtenhagen, Hannes
dc.contributor.authorVabret, Nicolas
dc.contributor.authorZiglio, Serena
dc.contributor.authorScarlatti, Gabriella
dc.contributor.authorShattock, Robin
dc.contributor.authorWahren, Britta
dc.contributor.authorGotch, Frances
dc.date.accessioned2018-05-07T14:35:18Z
dc.date.available2018-05-07T14:35:18Z
dc.date.created2011-05-10
dc.date.issued2011-04-12none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/reuOpjIiTuyWU/PDF/257dVo6jTh26Q.pdf
dc.identifier.urihttp://edoc.rki.de/176904/869
dc.description.abstractNovel, exciting intervention strategies to prevent infection with HIV have been tested in the past year, and the field is rapidly evolving. EUROPRISE is a network of excellence sponsored by the European Commission and concerned with a wide range of activities including integrated developmental research on HIV vaccines and microbicides from discovery to early clinical trials. A central and timely theme of the network is the development of the unique concept of co-usage of vaccines and microbicides. This review, prepared by the PhD students of the network captures much of the research ongoing between the partners. The network is in its 5th year and involves over 50 institutions from 13 European countries together with 3 industrial partners; GSK, Novartis and Sanofi- Pasteur. EUROPRISE is involved in 31 separate world-wide trials of Vaccines and Microbicides including 6 in African countries (Tanzania, Mozambique, South Africa, Kenya, Malawi, Rwanda), and is directly supporting clinical trials including MABGEL, a gp140-hsp70 conjugate trial and HIVIS, vaccine trials in Europe and Africa.eng
dc.language.isoeng
dc.publisherRobert Koch-Institut, Infektionskrankheiten / Erreger
dc.subjectHumanseng
dc.subjectAnimalseng
dc.subjectAIDS Vaccines/immunologyeng
dc.subjectClinical Trials as Topiceng
dc.subjectDrug Designeng
dc.subjectAnti-Infective Agents/immunologyeng
dc.subjectAntibody Formation/immunologyeng
dc.subject.ddc610 Medizin
dc.titleRational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10014135
dc.identifier.doi10.1186/1479-5876-9-40
dc.identifier.doihttp://dx.doi.org/10.25646/794
local.edoc.container-titleJournal of Translational Medicine
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://www.translational-medicine.com/content/9/1/40
local.edoc.container-publisher-nameBioMedCentral
local.edoc.container-volume9
local.edoc.container-issue40
local.edoc.container-year2011

Show simple item record